Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Condition(s):Small Cell Neuroendocrine Carcinoma of Bladder; Bladder Cancer; Urothelial Carcinoma BladderLast Updated:June 26, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Small Cell Neuroendocrine Carcinoma of Bladder; Bladder Cancer; Urothelial Carcinoma BladderLast Updated:June 26, 2023Recruiting
Condition(s):Endometrioma; EndometriosisLast Updated:April 6, 2023Recruiting
Condition(s):Negative Surgical MarginsLast Updated:May 31, 2023Not yet recruiting
Condition(s):Bladder CancerLast Updated:March 13, 2024Recruiting
Condition(s):Cystostomy InfectionLast Updated:September 25, 2017Completed
Condition(s):Ovarian Cyst BenignLast Updated:December 10, 2019Completed
Condition(s):Laparoscopic Radical CystectomyLast Updated:January 6, 2010Completed
Condition(s):Bladder CancerLast Updated:April 27, 2023Active, not recruiting
Condition(s):Invasive Bladder CancerLast Updated:March 9, 2022Completed
Condition(s):Bladder Cancer; Infections; Infection, Bacterial; Infection, Hospital; Infection Wound; Urinary Tract Infections; Urinary Bladder Diseases; Urinary Tract DiseaseLast Updated:December 10, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.